312
Participants
Start Date
December 15, 2022
Primary Completion Date
February 22, 2024
Study Completion Date
February 22, 2024
Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
US commercially approved Abiomed left sided hemodynamic support devices (Impella) will be included.
Impella RP with Sodium Bicarbonate used as purge solution
US commercially approved Abiomed right sided hemodynamic support devices (Impella) will be included.
UPMC Presbyterian, Pittsburgh
Advent Helath Orlando, Orlando
Tampa General Hospital, Tampa
University of Alabama, Birmingham
Christ Hospital, Cincinnatti
Henry Ford, Detroit
Ascension St. John Hospital, Detroit
Providence St. Patrick, Missoula
University of Nebraska, Omaha
Arkansas Heart Hospital, Little Rock
The Heart Hospital Baylor Plano, Plano
Baylor Scott and White (Baylor Heart and Vascular), Dallas
Pima Heart and Vascular (Tuscon Medical Center), Tucson
Keck USC Medical Center, Los Angeles
Montefiore Medical Center - Moses, Portland
Legacy Emanuel, Portland
Oregon Health & Science University, Portland
MultiCare Tacoma General, Tacoma
Providence Sacred Heart, Spokane
Robert Wood Johnson University Hospital, New Brunswick
Lead Sponsor
Abiomed Inc.
INDUSTRY